Fred Alger Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.6M Sell
430,339
-94,298
-18% -$3.43M 0.07% 135
2025
Q1
$19M Buy
524,637
+58,372
+13% +$2.11M 0.11% 114
2024
Q4
$19.6M Sell
466,265
-70,033
-13% -$2.95M 0.09% 137
2024
Q3
$29.8M Sell
536,298
-12,607
-2% -$700K 0.14% 108
2024
Q2
$22.6M Sell
548,905
-32,646
-6% -$1.34M 0.11% 121
2024
Q1
$27.2M Sell
581,551
-22,425
-4% -$1.05M 0.13% 125
2023
Q4
$28.9M Sell
603,976
-34,890
-5% -$1.67M 0.16% 120
2023
Q3
$22.8M Sell
638,866
-17,239
-3% -$615K 0.13% 137
2023
Q2
$30.3M Buy
656,105
+112,553
+21% +$5.19M 0.15% 136
2023
Q1
$21.8M Buy
543,552
+48,012
+10% +$1.93M 0.12% 160
2022
Q4
$23M Buy
495,540
+129,827
+35% +$6.01M 0.12% 156
2022
Q3
$15.1M Buy
365,713
+103,512
+39% +$4.29M 0.08% 182
2022
Q2
$15.6M Sell
262,201
-17,572
-6% -$1.05M 0.07% 184
2022
Q1
$20.3M Sell
279,773
-13,727
-5% -$997K 0.06% 183
2021
Q4
$24.7M Buy
293,500
+2,577
+0.9% +$217K 0.06% 194
2021
Q3
$26.2M Buy
290,923
+99,491
+52% +$8.97M 0.06% 191
2021
Q2
$18.3M Buy
191,432
+16,868
+10% +$1.61M 0.04% 211
2021
Q1
$19.9M Sell
174,564
-14,709
-8% -$1.67M 0.05% 201
2020
Q4
$26.2M Sell
189,273
-70,809
-27% -$9.8M 0.07% 184
2020
Q3
$21.4M Buy
260,082
+53,761
+26% +$4.42M 0.06% 161
2020
Q2
$16.1M Sell
206,321
-63,562
-24% -$4.97M 0.05% 174
2020
Q1
$12M Buy
269,883
+141,974
+111% +$6.31M 0.05% 174
2019
Q4
$5.46M Buy
127,909
+7,645
+6% +$327K 0.02% 225
2019
Q3
$5.15M Sell
120,264
-2,340
-2% -$100K 0.02% 218
2019
Q2
$7.79M Sell
122,604
-55,404
-31% -$3.52M 0.03% 194
2019
Q1
$12.3M Sell
178,008
-21,507
-11% -$1.49M 0.05% 180
2018
Q4
$8.68M Sell
199,515
-21,206
-10% -$922K 0.04% 183
2018
Q3
$16.9M Sell
220,721
-13,194
-6% -$1.01M 0.06% 168
2018
Q2
$18M Sell
233,915
-105,330
-31% -$8.1M 0.08% 156
2018
Q1
$17.3M Sell
339,245
-49,991
-13% -$2.55M 0.08% 156
2017
Q4
$18.1M Buy
389,236
+22,168
+6% +$1.03M 0.08% 148
2017
Q3
$19.6M Buy
367,068
+29,953
+9% +$1.6M 0.09% 143
2017
Q2
$20.9M Buy
337,115
+87,777
+35% +$5.45M 0.1% 133
2017
Q1
$16.9M Buy
249,338
+156,474
+168% +$10.6M 0.08% 142
2016
Q4
$6.53M Buy
92,864
+37,988
+69% +$2.67M 0.04% 173
2016
Q3
$3.89M Sell
54,876
-15,531
-22% -$1.1M 0.02% 214
2016
Q2
$3.44M Sell
70,407
-43,918
-38% -$2.15M 0.02% 228
2016
Q1
$7.24M Buy
114,325
+4,321
+4% +$274K 0.04% 218
2015
Q4
$12.3M Sell
110,004
-5,965
-5% -$669K 0.06% 161
2015
Q3
$11.2M Buy
115,969
+29,639
+34% +$2.85M 0.06% 170
2015
Q2
$8.84M Buy
86,330
+4,632
+6% +$474K 0.04% 240
2015
Q1
$5.07M Buy
81,698
+6,103
+8% +$379K 0.02% 341
2014
Q4
$3.32M Buy
+75,595
New +$3.32M 0.02% 360